As artificial intelligence becomes a go-to tool for everything from homework to workplace research, many people are also turning to chatbots like ChatGPT, Gemini, Claude, and Grok to verify whether ...
Bill Whitaker is an award-winning journalist and 60 Minutes correspondent who has covered major news stories, domestically and across the globe, for more than four decades with CBS News. This is an ...
French President Emmanuel Macron visits emergency forces, on the day of the G7 Summit in Evian-les-Bains, France, June 15, 2026. REUTERS/Christian Hartmann/Pool EVIAN-LES-BAINS, France, June 15 ...
Add Yahoo as a preferred source to see more of our stories on Google. An Iranian woman walks past an anti-Israeli mural, after U.S. and Iranian officials said they had reached a deal to end their war ...
June 8 (Reuters) - OpenAI said on Monday it has confidentially filed for a U.S. initial public offering, joining rival Anthropic in a push toward the stock market as investors seek exposure to the ...
WASHINGTON, June 12 (Reuters) - U.S. President Donald Trump said the United States has reached a deal to end the war with Iran, but the agreement has not been finalized and he has disputed accounts ...
June 12 (Reuters) - Elon Musk's SpaceX began trading on Nasdaq on Friday after the rocket and satellite maker raised $75 billion in its initial public offering, shattering records and eclipsing Saudi ...
FRANKFURT, June 24 (Reuters) - Franco-German tank maker KNDS rolled out its stock market listing plans on Wednesday, after months of talks over the balance of power within one of Europe's biggest ...
WASHINGTON, June 17 (Reuters) - The United States has so far not released the full text of the interim U.S.-Iran agreement to halt the war in Iran and open the Strait of Hormuz. But a draft copy ...
Business Insider sees AI as a valuable tool. Newsroom staff may employ approved AI tools to assist with drafting, transcription, research, data analysis, fact-checking, and more. There is always human ...
June 11 - Novo Nordisk (NOVOb.CO), opens new tab received UK approval for its oral weight-loss drug as the Danish drugmaker seeks to regain lost ground in a multibillion-dollar market shifting toward ...